The Science and Supply of GLP-1s with Chronis Manolis
Raising Health
Balancing Cost and Effectiveness of Therapies
Focusing on treating the highest risk individuals, competing with better efficacy and lower prices, and proving the cost benefit of therapies is essential. Pharmaceutical companies need to demonstrate the return on investment and move towards a whole-person approach to patient benefits. While there is a widespread coverage for diabetes treatments, weight loss therapies are not considered cost-effective currently.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
